Navigation Links
Laureate Pharma Welcomes Three New Members to Business Development Team
Date:11/2/2009

PRINCETON, N.J., Nov. 2 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and manufacture of monoclonal antibody products, fusion proteins and other recombinant protein products, today announced the addition of three new members to its Business Development team. "We're delighted to have three new team members with such extensive experience and expertise in outsourcing services and customer support joining our team," said Dan Leone, Vice President, Business Development. "We will have two team members covering eastern US/Canada and one covering western US/Canada."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

Andrew Arrage joins Laureate as Director, Business Development - East. Andrew has over 15 years of experience and a proven track record in the biopharmaceutical services industry, delivering services to clients in the biotech and pharmaceutical industries.

Patricia Caplan joins Laureate as Director, Business Development - East. Patricia brings more than 20 years of experience working with clients to develop their therapeutic protein products and move them from the bench into the clinic and on to commercialization.

Bruce Frazier joins Laureate as Manager, Business Development - West. Bruce, who most recently worked in business development at a biopharmaceutical services company, has applied his experience as a quality control skilled scientist to become an accomplished business development professional dedicated to serving clients requiring biopharmaceutical testing and manufacturing services.

"Andrew, Patricia and Bruce add great depth and valuable experience to our business development team," said Robert J. Broeze, Ph.D., President and CEO of Laureate. "With their strong customer service and project management skills they will play a key role in expanding Laureate's portfolio of client projects and providing critical support to our customer base."

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, NJ. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. For more information, contact Dan Leone, Vice President, Business Development at 609-919-3300, or info@laureatepharma.com or visit www.laureatepharma.com.

Available Topic Expert: For information on the listed expert, click appropriate link.

Robert Broeze

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=84360

SOURCE Laureate Pharma, Inc.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Predicts Nobel Laureates
2. Laureate Pharma Elects New Board Member
3. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
4. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
5. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
6. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
7. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
8. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
9. Laureate Announces Manufacturing Agreement with Tolerx
10. Laureate Pharma to Add More Manufacturing Capacity
11. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... analysis platform specifically designed for life science researchers to analyze and interpret ... Rosalind Franklin, who made a major contribution to the discovery of the ...
(Date:10/11/2017)... ... ... wash is a basic first aid supply for any work environment, but most personal eye ... first if a dangerous substance enters both eyes? It’s one less decision, and likely quicker ... eye piece. , “Whether its dirt and debris, or an acid or alkali, getting anything ...
(Date:10/11/2017)... INDIANAPOLIS , Oct. 11, 2017  VMS BioMarketing, a ... of a nationwide oncology Clinical Nurse Educator (CNE) network, which ... growing need for communication among health care professionals to enhance ... physicians, nurses, office staff, and other health care professionals to ... for breast cancer. ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... maternal age to IVF success. , After comparing the results from the fresh ...
Breaking Biology Technology:
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):